- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- May 2024
- 132 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Report
- March 2025
- 97 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
- Report
- April 2025
- 50 Pages
Global
From €2412EUR$2,650USD£2,068GBP
Penicillamine is a drug used to treat immune disorders, such as rheumatoid arthritis, systemic lupus erythematosus, and cystinuria. It works by binding to and breaking down certain proteins in the body, which helps reduce inflammation and pain. It is also used to reduce the amount of copper in the body, which can help treat Wilson's disease. Penicillamine is available in both oral and injectable forms.
Penicillamine is a generic drug, meaning it is available from multiple manufacturers. It is also available in combination with other drugs, such as methotrexate and hydroxychloroquine. The drug is typically prescribed by a doctor and is available in pharmacies and online.
In the market for immune disorder drugs, penicillamine is a popular choice due to its effectiveness and affordability. It is widely used to treat a variety of conditions, and is often prescribed in combination with other drugs.
Some companies that produce penicillamine include Mylan, Teva Pharmaceuticals, and Sandoz. Show Less Read more